SEC Tracker
Get the app

Oruka Therapeutics ORKA

Oruka Therapeutics (ORKA) reports insider sales

Lawrence Otto Klein, insider filing for ORKA

Form
4
Filed
Importance
Routine
  1. Oct 1, 2026: 25,000 shares purchased at $7.8
  2. Oct 1, 2026: 16,246 shares sold at $83.3979
  3. Oct 1, 2026: 8,554 shares sold at $84.0256
  4. Oct 1, 2026: 200 shares sold at $84.78

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Oruka Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. CytomX Therapeutics CTMX public float $372M, Jun 30, 2025
  2. Cronos Group CRON public float $380M, Jun 30, 2025
  3. REGENXBIO RGNX public float $385M, Jun 30, 2025
  4. Capricor Therapeutics CAPR public float $399M, Jun 30, 2025
  5. Cryoport CYRX public float $400M, Jun 30, 2025